Cost effectiveness of finasteride: a risky business?

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.607, 2010-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost effectiveness of adjuvant chemotherapy a generation game?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 634, 2011-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Cost effectiveness of risperidone: is compliance the key?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 614, 2010-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Do physicians consider cost effectiveness in clinical practice?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 301, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

ICD cost effectiveness over-rated?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 495, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

The (Near) Equivalence of Cost-Effectiveness and Cost-Benefit Analyses: Fact or Fallacy?

By Donaldson C.

PharmacoEconomics, Vol. 13, Iss. 4, 1998-04 ,pp. : 389-396

Adis International

Access to resources Recommend Favorite